Gold tier: mechanically validated evidence, with its primary source.
58 evidence items · page 3 / 3
84 %The combined proportion of women aged 25 to 49 years who underwent cervical precancer treatment across Cabo Verde, Malawi, United Republic of Tanzania and Zambia was 84% in 2020.
Malawi · Zambielésions précancéreuses du col (CIN)observed 2020Africa CDCdocument of 51 observations
56 %56% of women at risk of cervical cancer in Zambia live in rural areas.
Zambiecancer du col de l'utérusAfrica CDCdocument of 52 observations
16 %The prevalence of low birth weight was 16.0% among 2999 newborns born to pregnant women with malaria in Burkina Faso, Ghana, Malawi, and Zambia.
Burkina Faso · Ghana · Malawi · Zambiefaible poids de naissancepublished 2019Malaria journaleurope_pmcdocument of 6 observations
40,000 womenIn 2023, more than 40,000 women in Zambia were screened using the HPV-based method.
Zambieinfection à HPVobserved 2023Africa CDCdocument of 51 observations
300 genomesZambia contributed 300 Vibrio cholerae genomes collected between 2023 and 2024.
Zambiecholéraobserved 2023-2024Africa CDCdocument of 21 observations
26 %Overall cervical cancer screening coverage at population level in Zambia is low at about 26%.
Zambiecancer du col de l'utérusAfrica CDCdocument of 51 observations
89 %In Kenya and Zambia, 89% of participants reported previous malaria diagnoses.
Kenya · Zambiepaludismepublished 2025Malaria journalPubMeddocument of 5 observations
10 provincesAs of 2021, Zambia had expanded HPV testing to all 10 provinces.
Zambieinfection à HPVobserved 2021Africa CDCdocument of 51 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.